FDA Approved: NICOTINE — Supplemental Application (P & L Development, LLC)

View source ↗

Summary

FDA approved a supplemental application for NICOTINE POLACRILEX, a nicotine replacement therapy, from P & L Development, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Nicotine (nicotine)

Snippet

SUPPL AP for NICOTINE (NICOTINE POLACRILEX)